Matches in SemOpenAlex for { <https://semopenalex.org/work/W1976144347> ?p ?o ?g. }
Showing items 1 to 88 of
88
with 100 items per page.
- W1976144347 abstract "Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, ILIntroduction: Preclinical studies have shown that dietary carbohydrate restriction slows prostate tumor growth in multiple xenograft models in part due to a reduction insulin-like growth factor (IGF) axis signaling. Pomegranate extract (PE) has been shown to slow prostate tumor growth in-vitro and in vivo similarly through this pathway, as well as decrease markers of angiogenesis and inflammation. In this study, we determined the dose-response of PE on prostate tumor growth in the setting of dietary carbohydrate restriction in a slow-growing mouse xenograft model. For this study, we chose a standardized PE (POMx, Pom Wonderful, Los Angeles, CA), at doses which are easily translatable to human equivalents. Materials and Methods: Male athymic nude mice housed 5 per cage (n = 130) were subcutaneously injected with 1 × 10^5 LAPC-4 cells after a 10 day acclimation period. 14 days post-injection, all mice were all placed on an ad-libitum no-carbohydrate ketogenic diet (NCKD: 83% fat, 0% carbohydrate, 17% protein) (day 0). Each cage was randomly assigned to 1 of 4 doses of PE (placebo = 0 mg, low dose = 2.62 mg, intermediate dose = 5.25mg, or high dose = 7.87mg) suspended in 0.2 mL of PBS delivered via oral gavage 5 days per week. These doses are equivalent to 0, 1, 2, or 3 POMx capsules/day consumed by a 70 kg human. Mice will be sacrificed when tumors reach ≥1,000 mm^3. Results: At randomization, there were no differences in median body weight among groups (p = 0.623). Currently, at day 32, overall survival is decreased in the placebo group (hazard ratio 2.26, 95% confidence interval, 0.83 - 6.10, p = 0.109) relative to the low dose PE group with no survival differences among PE groups. Median tumor volumes for the placebo group are 83.3mm^3, compared to 74.5mm^3, 76.3mm^3, and 70.1mm^3 for the low, intermediate, and high PE doses respectively, which are not statistically different (p = 0.98). Conclusions: Preliminary data show a trend toward improved survival with the combination of an NCKD and PE at the selected doses. Currently, tumor volumes are not significantly different, however completed results will be presented.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 5631. doi:1538-7445.AM2012-5631" @default.
- W1976144347 created "2016-06-24" @default.
- W1976144347 creator A5012207710 @default.
- W1976144347 creator A5014972613 @default.
- W1976144347 creator A5036003731 @default.
- W1976144347 creator A5067618392 @default.
- W1976144347 creator A5086448556 @default.
- W1976144347 creator A5090928660 @default.
- W1976144347 date "2012-04-15" @default.
- W1976144347 modified "2023-09-27" @default.
- W1976144347 title "Abstract 5631: The effect of pomegranate extract dose on prostate cancer growth in a carbohydrate restricted mouse xenograft model" @default.
- W1976144347 doi "https://doi.org/10.1158/1538-7445.am2012-5631" @default.
- W1976144347 hasPublicationYear "2012" @default.
- W1976144347 type Work @default.
- W1976144347 sameAs 1976144347 @default.
- W1976144347 citedByCount "0" @default.
- W1976144347 crossrefType "proceedings-article" @default.
- W1976144347 hasAuthorship W1976144347A5012207710 @default.
- W1976144347 hasAuthorship W1976144347A5014972613 @default.
- W1976144347 hasAuthorship W1976144347A5036003731 @default.
- W1976144347 hasAuthorship W1976144347A5067618392 @default.
- W1976144347 hasAuthorship W1976144347A5086448556 @default.
- W1976144347 hasAuthorship W1976144347A5090928660 @default.
- W1976144347 hasConcept C118552586 @default.
- W1976144347 hasConcept C121608353 @default.
- W1976144347 hasConcept C126322002 @default.
- W1976144347 hasConcept C134018914 @default.
- W1976144347 hasConcept C142724271 @default.
- W1976144347 hasConcept C150903083 @default.
- W1976144347 hasConcept C17093226 @default.
- W1976144347 hasConcept C204787440 @default.
- W1976144347 hasConcept C207001950 @default.
- W1976144347 hasConcept C27081682 @default.
- W1976144347 hasConcept C2776235491 @default.
- W1976144347 hasConcept C2778186239 @default.
- W1976144347 hasConcept C2778587478 @default.
- W1976144347 hasConcept C2778977261 @default.
- W1976144347 hasConcept C2780192828 @default.
- W1976144347 hasConcept C2780394083 @default.
- W1976144347 hasConcept C71924100 @default.
- W1976144347 hasConcept C86803240 @default.
- W1976144347 hasConcept C98274493 @default.
- W1976144347 hasConceptScore W1976144347C118552586 @default.
- W1976144347 hasConceptScore W1976144347C121608353 @default.
- W1976144347 hasConceptScore W1976144347C126322002 @default.
- W1976144347 hasConceptScore W1976144347C134018914 @default.
- W1976144347 hasConceptScore W1976144347C142724271 @default.
- W1976144347 hasConceptScore W1976144347C150903083 @default.
- W1976144347 hasConceptScore W1976144347C17093226 @default.
- W1976144347 hasConceptScore W1976144347C204787440 @default.
- W1976144347 hasConceptScore W1976144347C207001950 @default.
- W1976144347 hasConceptScore W1976144347C27081682 @default.
- W1976144347 hasConceptScore W1976144347C2776235491 @default.
- W1976144347 hasConceptScore W1976144347C2778186239 @default.
- W1976144347 hasConceptScore W1976144347C2778587478 @default.
- W1976144347 hasConceptScore W1976144347C2778977261 @default.
- W1976144347 hasConceptScore W1976144347C2780192828 @default.
- W1976144347 hasConceptScore W1976144347C2780394083 @default.
- W1976144347 hasConceptScore W1976144347C71924100 @default.
- W1976144347 hasConceptScore W1976144347C86803240 @default.
- W1976144347 hasConceptScore W1976144347C98274493 @default.
- W1976144347 hasLocation W19761443471 @default.
- W1976144347 hasOpenAccess W1976144347 @default.
- W1976144347 hasPrimaryLocation W19761443471 @default.
- W1976144347 hasRelatedWork W1443108546 @default.
- W1976144347 hasRelatedWork W1483779827 @default.
- W1976144347 hasRelatedWork W2000786152 @default.
- W1976144347 hasRelatedWork W2016400880 @default.
- W1976144347 hasRelatedWork W2024266842 @default.
- W1976144347 hasRelatedWork W2318118644 @default.
- W1976144347 hasRelatedWork W2323099604 @default.
- W1976144347 hasRelatedWork W2328602479 @default.
- W1976144347 hasRelatedWork W2354189070 @default.
- W1976144347 hasRelatedWork W2356481950 @default.
- W1976144347 hasRelatedWork W2376976586 @default.
- W1976144347 hasRelatedWork W2388342914 @default.
- W1976144347 hasRelatedWork W2388762021 @default.
- W1976144347 hasRelatedWork W2389631441 @default.
- W1976144347 hasRelatedWork W2391681026 @default.
- W1976144347 hasRelatedWork W2392213084 @default.
- W1976144347 hasRelatedWork W2563485399 @default.
- W1976144347 hasRelatedWork W2784043644 @default.
- W1976144347 hasRelatedWork W2978553166 @default.
- W1976144347 hasRelatedWork W3080706624 @default.
- W1976144347 isParatext "false" @default.
- W1976144347 isRetracted "false" @default.
- W1976144347 magId "1976144347" @default.
- W1976144347 workType "article" @default.